Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas with SMO/AKT/NF2 Mutations.
For more information about this clinical trial, click here
Schema & Eligibility Alliance A071401
CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Mercy Hospital, Oklahoma City, OK
Ask your physician about participating in this clinical trial or call us.